These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2428716)

  • 1. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification.
    Pintera J; Krácmar C; Pinterová A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ways of post-transfusion hepatitis prevention.
    Pintera J
    Czech Med; 1989; 12(3):149-57. PubMed ID: 2509173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for circulating immune complexes in blood donors as an effective method of further HBsAg carriers detection.
    Pintera J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(3):455-61. PubMed ID: 6169608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical problem of hepatitis transmission;
    Barker LF; Gerety RJ
    Prog Clin Biol Res; 1976; 11():163-82. PubMed ID: 799307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of HBsAg and post-transfusional hepatitis type B.
    Bedarida G; D'Agostino F; Lavezzi C; Tamagni F
    Boll Ist Sieroter Milan; 1978 May; 57(2):160-4. PubMed ID: 728267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B antigen - post transfusion studies in Papua New Guinea.
    Woodfield DG
    Trop Geogr Med; 1977 Sep; 29(3):257-65. PubMed ID: 595131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radioimmunoassay and counterimmunoelectrophoresis for the detection of hepatitis B surface antigen carriers in a high-prevalence region.
    Sandler SG; Knecht A; Amar A; Davidowitch R
    Isr J Med Sci; 1979 Jul; 15(7):579-82. PubMed ID: 478821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'How frequent is posttranfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature?
    Vox Sang; 1977; 32(6):346-63. PubMed ID: 898833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of the distribution of hepatitis B markers among blood donors and patients with post-transfusion hepatitis in the city of Sofia].
    Gubev E; Rashkov R; Dimitrova T; Sharankov N; Andonov A
    Vutr Boles; 1987; 26(3):38-43. PubMed ID: 3617705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-transfusion hepatitis. Effects of long-term screening for HBsAg carriers among blood donors].
    Pintera J
    Cas Lek Cesk; 1982 Sep; 121(37):1148-52. PubMed ID: 7139671
    [No Abstract]   [Full Text] [Related]  

  • 16. Albumin interaction with HBsAg as one of the possible sources of the polyethylene glycol "immune complexes" turbidity in hepatitis B.
    Pintera J; Jurák J
    Acta Virol; 1982 Jan; 26(1-2):86-90. PubMed ID: 6124114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HBV genome by gene amplification method in HBsAg negative blood donors.
    Bodhiphala P; Chaturachumroenchai S; Chiewsilp P; Pruksananonda P
    J Med Assoc Thai; 1999 May; 82(5):491-5. PubMed ID: 10443099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of posttransfusion hepatitis B virus infection.
    Wang D; Tan D; Cao X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):77-9. PubMed ID: 11503032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.